Related Experiment Video
Updated: Feb 13, 2026

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression
Liwei Lang1, Austin Y Shull2, Yong Teng1,3,4
1Department of Oral Biology, Augusta University, Augusta, GA 30912, United States.
Abstract:
Coordination between the amplification of the fibroblast growth factor FGF19, overexpression of its corresponding receptor FGFR4, and hyperactivation of the downstream transmembrane enzyme β-klotho has been found to play pivotal roles in mediating tumor development and progression. Aberrant FGF19-FGFR4 signaling has been implicated in driving specific tumorigenic events including cancer cell proliferation, apoptosis resistance, and metastasis by activating a myriad of downstream signaling cascades. As an attractive target, several strategies implemented to disrupt the FGF19-FGFR4 axis have been developed in recent years, and FGF19-FGFR4 binding inhibitors are being intensely evaluated for their clinical use in treating FGF19-FGFR4 implicated cancers. Based on the established work, this review aims to detail how the FGF19-FGFR4 signaling pathway plays a vital role in cancer progression and why disrupting communication between FGF19 and FGFR4 serves as a promising therapeutic strategy for disrupting cancer progression.
Insights
Fibroblast growth factor FGF19 and its receptor FGFR4 signaling drive tumor growth. Inhibiting this FGF19-FGFR4 axis is a promising strategy for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Signal Transduction
Background:
- The fibroblast growth factor FGF19-fibroblast growth factor receptor 4 (FGFR4) signaling pathway is crucial in tumor development.
- Overexpression of FGF19 and FGFR4, along with hyperactivation of β-klotho, promotes cancer progression.
- Aberrant FGF19-FGFR4 signaling drives cancer cell proliferation, apoptosis resistance, and metastasis.
Purpose of the Study:
- To review the role of the FGF19-FGFR4 signaling pathway in cancer progression.
- To highlight the therapeutic potential of targeting the FGF19-FGFR4 axis.
Main Methods:
- Literature review of studies investigating the FGF19-FGFR4 signaling pathway in cancer.
- Analysis of current therapeutic strategies targeting the FGF19-FGFR4 axis.
Main Results:
- The FGF19-FGFR4 pathway is a key mediator of tumorigenesis through various downstream signaling cascades.
- Inhibitors targeting FGF19-FGFR4 binding are under clinical evaluation for cancer treatment.
Conclusions:
- Disrupting FGF19-FGFR4 communication is a promising therapeutic strategy for cancers driven by this pathway.
- Targeting the FGF19-FGFR4 axis offers a potential avenue for novel cancer therapies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hypothalamic-Pituitary Axis
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Moment of a Force About an Axis: Scalar
To better understand the concept of moment of force, consider the example of a cyclist riding a bicycle. When the cyclist applies force on...

